Analyst Ratings for Lyra Therapeutics (LYRA)

LYRA Rating Summary

  |   Expand Research on LYRA
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 1.7 / 10   Percentile Rank: 12%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/7/2024 H.C. Wainwright
» Updated 6/9/2025		 Matthew Caufield Downgrade Neutral
(Buy)		 16.00
(2.00)		 0.52
(1.28)		 146.15% Details
5/7/2024 BofA Securities Jason Gerberry Downgrade Underperform
(Buy)		 0.35
(N/A)		 0.52
(1.28)		 146.15% Details